Monosomy 13q14 syndrome

Monosomy 13q14 syndrome, also known as 13q14 deletion syndrome or chromosome 13q14 deletion syndrome, is a rare chromosomal disorder caused by a partial deletion of the long arm of chromosome 13 at band q14. This region is notable for containing the RB1 gene (retinoblastoma 1 gene), and deletions in this area are classically associated with an increased risk of retinoblastoma, a malignant tumor of the retina that typically presents in early childhood. The syndrome affects multiple body systems depending on the size and exact location of the deletion. Clinical features of monosomy 13q14 syndrome are variable but commonly include intellectual disability of varying severity, growth retardation, craniofacial dysmorphism (such as a broad prominent nasal bridge, short nose, micrognathia, and low-set ears), and eye abnormalities including retinoblastoma and sometimes microphthalmia. Additional features may include congenital heart defects, genital anomalies (particularly in males, such as hypospadias or cryptorchidism), and skeletal anomalies. Some patients may also present with hypotonia and developmental delay. The phenotype is highly variable and depends on the extent of the chromosomal deletion — larger deletions tend to produce more severe and widespread manifestations. Management of monosomy 13q14 syndrome requires a multidisciplinary approach. Surveillance for retinoblastoma is critical and includes regular ophthalmologic examinations beginning in infancy. Treatment of retinoblastoma may involve chemotherapy, laser therapy, cryotherapy, or enucleation depending on the stage and severity. Developmental support including early intervention programs, speech therapy, and physical therapy are important for optimizing outcomes. Cardiac and other congenital anomalies are managed according to standard clinical protocols. Genetic counseling is recommended for affected families. There is no cure for the underlying chromosomal abnormality.

Common questions about Monosomy 13q14 syndrome